Get ready for two power‑packed hours where science meets breakthrough innovation. We’re diving into how multimodal insights—and the 5 and 6‑base genome—are reshaping the way we decode biology, understand disease, and accelerate discovery.
You’ll explore how distinguishing 5mC, 5hmC, and all four canonical bases in a single experiment unlocks a richer, more dimensional view of biology. Whether you’re hunting for new biomarkers, refining hypotheses, or simply curious about the next generation of molecular tools, you’re in the right room.
We will provide the lunch to fuel your curiosity, and let’s jump into the future of multiomics together.
Agenda Highlights
•Welcome: Steven Ciaramaglia, Territory Acccout Manager, biomodal
•Technology Showcase: Mark Consugar, Assoc. Dir. of Scientific Affairs, biomoal – Explore the capabilities of biomodal’s duet evoC technology, which simultaneously detects two epigenetic markers (5mC and 5hmC) alongside the four standard DNA bases (A, T, G, C) with high accuracy from a single, low-input DNA sample. This multiomic approach streamlines the discovery process.
•Scientific Insights: Jing Zhao, PhD Student, McGill University – Disentangling 5-methylcytosine and 5-hydroxymethylcytosine Signaling in Clear Cell Renal Cell Carcinoma.
•Platform Services: Tony Kwan, Project Manager, McGill Genome Centre – Platform Services at the McGill Genome Centre
It is free to attend. Please register your attendance below.
